|

Cyclophophamide Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Allogene Therapeutics1

Indications

  • Systemic Lupus Erythematosus (With and Without Nephritis)1
  • Idiopathic Inflammatory Myopathy1
  • Systemic Sclerosis1
  • Lupus1

Phoenix, Arizona1 trial

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Mayo Clinic

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.